News

Silicon Valley Cash Is Still Chasing Blood Despite Theranos Bust

Genalyte’s Diagnostic Tool Shows Potential to Improve Turnaround Time in RA, Other Conditions

With $36 Million in New Funding, Can Genalyte Achieve What Theranos Touted?

Genalyte raises $36 million from Khosla for its one-drop blood test

Can Genalyte achieve what Theranos touted?

Near Patient Anti-Nuclear Antibody Multiplex Testing Using Whole Blood for the Diagnosis of Connective Tissue Diseases in a Tertiary Care Center

Application of a Novel Anti-Nuclear Antibody Multiplex Test Using Fingerstick and Venous Whole Blood in a Rheumatology Clinic

Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arrays

Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arrays

Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform